Skip to content

Clinical trials

Completed Phase 3 Heart Defects, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Phase 3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20041
20064
20091
20132
20141
20151
20173
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
National Cardiovascular Center Harapan Kita Hospital Indonesia2
Sanofi2
Actelion1
Asklepion Pharmaceuticals, LLC1
Boston Children's Hospital1
Children's Hospital of Fudan University1
Children's National Research Institute1
Encysive Pharmaceuticals1
Insel Gruppe AG, University Hospital Bern1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital22
Cardiovascular Diseases3
Heart Diseases3
Transposition of Great Vessels3
Euthyroid Sick Syndromes2
Hypertension, Pulmonary2
Thrombosis2
Acute Kidney Injury1
Acute Lung Injury1
Cardiac Output, Low1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.